These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 38666971)
21. Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study. Hassoun-Kheir N; Hussein K; Karram M; Saffuri M; Badaan S; Peleg S; de Kraker MEA; Aboelhega W; Warman S; Alon T; Eluk O; Geffen Y; Paul M Clin Microbiol Infect; 2023 May; 29(5):629-634. PubMed ID: 36641053 [TBL] [Abstract][Full Text] [Related]
22. Bacteremia with Carbapenemase-Producing Averbuch D; Moshkovitz L; Ilan S; Abu Ahmad W; Temper V; Strahilevitz J Microb Drug Resist; 2022 May; 28(5):593-600. PubMed ID: 35580283 [TBL] [Abstract][Full Text] [Related]
23. Investigating Resistance to Carbapenems in Enterobacterales: A Descriptive Epidemiological Study of 2021 Screening in an Italian Teaching Hospital. De Vita E; De Angelis L; Arzilli G; Baglivo F; Barnini S; Vecchione A; Baggiani A; Rizzo C; Porretta AD; Teams Aid Pathogens; 2023 Sep; 12(9):. PubMed ID: 37764948 [TBL] [Abstract][Full Text] [Related]
24. Predominance of Non-carbapenemase Producing Carbapenem-Resistant Enterobacterales in South Texas. Black CA; So W; Dallas SS; Gawrys G; Benavides R; Aguilar S; Chen CJ; Shurko JF; Lee GC Front Microbiol; 2020; 11():623574. PubMed ID: 33643226 [TBL] [Abstract][Full Text] [Related]
25. Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-Nonsusceptible Kazmierczak KM; Karlowsky JA; de Jonge BLM; Stone GG; Sahm DF Antimicrob Agents Chemother; 2021 Jun; 65(7):e0200020. PubMed ID: 33972241 [TBL] [Abstract][Full Text] [Related]
26. Association of Carbapenemase-Producing Sung GH; Kim SH; Park EH; Hwang SN; Kim JD; Kim GR; Kim EY; Jeong J; Kim S; Shin JH Front Microbiol; 2022; 13():923979. PubMed ID: 35756058 [TBL] [Abstract][Full Text] [Related]
27. Differences in the Distribution of Species, Carbapenemases, Sequence Types, Antimicrobial Heteroresistance and Mortality Rates Between Pediatric and Adult Carbapenemase-Producing Yu H; Ma D; Liu B; Yang S; Lin Q; Yu R; Jia X; Niu S; Zhang Q; Huang S Front Med (Lausanne); 2022; 9():827474. PubMed ID: 35360726 [TBL] [Abstract][Full Text] [Related]
28. Updates on the Status of Carbapenem-Resistant Enterobacterales in Lebanon. Fadlallah M; Salman A; Salem-Sokhn E Int J Microbiol; 2023; 2023():8831804. PubMed ID: 37283804 [TBL] [Abstract][Full Text] [Related]
29. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control. Tängdén T; Giske CG J Intern Med; 2015 May; 277(5):501-12. PubMed ID: 25556628 [TBL] [Abstract][Full Text] [Related]
31. Poor infection prevention and control standards are associated with environmental contamination with carbapenemase-producing Enterobacterales and other multidrug-resistant bacteria in Swiss companion animal clinics. Schmidt JS; Kuster SP; Nigg A; Dazio V; Brilhante M; Rohrbach H; Bernasconi OJ; Büdel T; Campos-Madueno EI; Gobeli Brawand S; Schuller S; Endimiani A; Perreten V; Willi B Antimicrob Resist Infect Control; 2020 Jun; 9(1):93. PubMed ID: 32576281 [TBL] [Abstract][Full Text] [Related]
32. Clinical and Demographic Characteristics of Patients With a New Diagnosis of Carriage or Clinical Infection With Carbapenemase-Producing Adar A; Zayyad H; Azrad M; Libai K; Aharon I; Nitzan O; Peretz A Front Public Health; 2021; 9():616793. PubMed ID: 33614584 [No Abstract] [Full Text] [Related]
33. Nationwide, population-based observational study of the molecular epidemiology and temporal trend of carbapenemase-producing Enterobacterales in Norway, 2015 to 2021. Ljungquist O; Haldorsen B; Pöntinen AK; Janice J; Josefsen EH; Elstrøm P; Kacelnik O; ; Sundsfjord A; Samuelsen Ø; Euro Surveill; 2023 Jul; 28(27):. PubMed ID: 37410381 [TBL] [Abstract][Full Text] [Related]
34. Duration of carriage of multidrug-resistant bacteria in dogs and cats in veterinary care and co-carriage with their owners. Dazio V; Nigg A; Schmidt JS; Brilhante M; Campos-Madueno EI; Mauri N; Kuster SP; Brawand SG; Willi B; Endimiani A; Perreten V; Schuller S One Health; 2021 Dec; 13():100322. PubMed ID: 34522760 [TBL] [Abstract][Full Text] [Related]
35. Diversity of Carbapenemase-Producing Escherichia coli Isolates in France in 2012-2013. Gauthier L; Dortet L; Cotellon G; Creton E; Cuzon G; Ponties V; Bonnin RA; Naas T Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866863 [TBL] [Abstract][Full Text] [Related]
36. Comparison of nine different selective agars for the detection of carbapenemase-producing Enterobacterales (CPE). Göttig S; Walker SV; Saleh A; Koroska F; Sommer J; Stelzer Y; Steinmann J; Hamprecht A Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):923-927. PubMed ID: 31902017 [TBL] [Abstract][Full Text] [Related]
37. Carbapenem-Resistant Enterobacterales, Carbapenem Resistant Organisms, Carbapenemase-Producing Enterobacterales, and Carbapenemase-Producing Organisms: Terminology Past its "Sell-By Date" in an Era of New Antibiotics and Regional Carbapenemase Epidemiology. Livermore DM; Nicolau DP; Hopkins KL; Meunier D Clin Infect Dis; 2020 Oct; 71(7):1776-1782. PubMed ID: 32025698 [TBL] [Abstract][Full Text] [Related]
38. The Natural History of Carbapenemase-Producing Enterobacterales: Progression From Carriage of Various Carbapenemases to Bloodstream Infection. Temkin E; Solter E; Lugassy C; Chen D; Cohen A; Schwaber MJ; Carmeli Y; Clin Infect Dis; 2024 Jul; 79(1):22-29. PubMed ID: 38447961 [TBL] [Abstract][Full Text] [Related]